YUNGJIN PHARM. CO., LTD (영진약품(주))
KOSPI Stock Code: 003520 | DART Corp Code: 00141149
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | YUNGJIN PHARM. CO., LTD |
|---|---|
| Korean legal name | 영진약품(주) |
| Alternate names | 영진약품 |
| Market | KOSPI |
| Stock Code | 003520 |
| DART Corp Code | 00141149 |
| CEO | 이기수 |
| Business Registration No. | 2188100352 |
| Corporate Registration No. | 1101110043127 |
| Established Date | 1962-07-16 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층 |
| Homepage | https://www.yungjin.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260312000801 |
| verified_at | 2026-11-01T02:19:15.420Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: OFS (Separate) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260312000801
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 254,255,894,053 | KRW 252,040,228,764 |
| Operating Income (영업이익) | KRW 3,415,589,622 | KRW 8,721,997,142 |
| Net Income (당기순이익) | KRW -227,660,610 | KRW 1,232,792,247 |
| Total Assets (자산총계) | KRW 262,384,700,788 | KRW 234,257,972,953 |
| Total Liabilities (부채총계) | KRW 170,925,251,581 | KRW 144,454,841,644 |
| Total Equity (자본총계) | KRW 91,459,449,207 | KRW 89,803,131,309 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-08 | 20261008800579 | [Corrected description]Conclusion of Single Sales Contract or Supply Contract | [기재정정]단일판매ㆍ공급계약체결 | 영진약품 |
2026-09-01 | 20260901800684 | Filing or Application of Lawsuit, etc. (Claim of over Certain Amount) | 소송등의제기ㆍ신청(일정금액이상의청구) | 영진약품 |
2026-08-28 | 20260828000018 | Disclosure of Current Status of Large-scale Business Groups [Quarterly Disclosure (For individual company)] | 대규모기업집단현황공시[분기별공시(개별회사용)] | 영진약품 |
2026-08-14 | 20260814002103 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 영진약품 |
2026-08-13 | 20260813000231 | Matters concerning payment amount for each payment method-payment period and Dispute Resolution Organization | 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 | 영진약품 |
2026-08-12 | 20260812800977 | [Corrected description]Conclusion of Single Sales Contract or Supply Contract | [기재정정]단일판매ㆍ공급계약체결 | 영진약품 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260312000801 | verified_at: 2026-11-01T02:19:15.420Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.